Name (Synonyms) | Correlation | |
---|---|---|
D004066 | Digestive System Diseases NIH | 0.58 |
D005767 | Gastrointestinal Diseases NIH | 0.58 |
D003141 | Communicable Diseases NIH | 0.09 |
D007239 | Infection NIH | 0.06 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0011024 | Abnormality of the gastrointestinal tract HPO | 0.41 |
There is one clinical trial.
In December 2019, an outbreak of pneumonia associated with a novel coronavirus named as severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) was reported in Wuhan city, China, and spread exponentially throughout China and other countries in the following weeks. It is recommended that elective endoscopies should be deferred during the COVID-19 outbreak for the potential transmission between patients and medical staff in the statements of Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements). Therefore, exploring an alternative for patients with the requirements of endoscopy during the outbreak is of great importance. Herein,the investigators developed an novel non-contact magnetically-controlled capsule endoscopy (Nc-MCE) system (Figure 1) adds a remote control workstation and a audio-visual exchange system to the original well-established MCE system. This study was a open-label, prospective, randomized controlled study approved by the institutional review board of Shanghai Changhai Hospital. It was designed to evaluate the diagnostic utility, safety, feasibility and patients acceptability of Nc-MCE in patients with an indication of endoscopy, and comparing it with the result of MCE.
Description: Maneuverability score was the sum of four subjective scores rated by the operator (signal transmission quality score, operating comfort score, gastric visualization score and study subject compliance score), each of which ranged from 1 to 5 denoting the lowest to the highest degree of satisfaction.
Measure: Maneuverability score Time: During the procedureDescription: GET was defined as the time time taken for the endoscopist to complete the gastric examination to his or her satisfaction
Measure: Gastric examination time(GET) Time: During the procedureDescription: The investigators use a satisfaction questionnaire to evaluate the comfort and acceptability of each patient
Measure: the comfort and acceptability of patients Time: After the procedure(within 5 days)Description: Diagnosis based on the data of nc- MCE by two endoscopist
Measure: diagnostic yield Time: after the procedure(within 5 days)Description: Adverse events during and after the procedure
Measure: Adverse events Time: During and within 2 weeks after the procedureDescription: Complete observation of the mucosa (>90% of the mucosa observed) in gastric cardia, fundus, body, angulus, antrum and pylorus
Measure: Clinical success Time: During the procedure